NCT00974376

Gabapentin Treatment of Cannabis Dependence

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 150 (actual)
• Sponsor: The Scripps Research Institute · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This is a clinical study to evaluate the efficacy of the medication gabapentin in treating persons with cannabis dependence.

Detailed description

This is a 12-week, double blind, placebo controlled study to evaluate the efficacy of gabapentin in treating outpatients with cannabis dependence. After an initial phone screen, a comprehensive screening visit is scheduled to determine eligibility. Upon enrollment, counseling, medication dispensation and research assessments occur 1 time per week for 3 months.

Conditions

• Cannabis Dependence
• Cannabis Withdrawal
• Cognitive Deficits

Interventions

Type	Name	Description
DRUG	gabapentin 1200mg/day	gabapentin 1200mg/day for 12 weeks
DRUG	Placebo	1200mg/day of placebo for 12 weeks
BEHAVIORAL	Manual-guided behavioral counseling	Standardized manual-guided behavioral counseling performed 1 time per week for 12 weeks in conjunction with study drug or placebo.

Timeline

• Start date: 2009-11-04
• Primary completion: 2016-05-19
• Completion: 2016-05-19
• First posted: 2009-09-10
• Last updated: 2017-06-06
• Results posted: 2017-06-06

Locations

1 site across 1 country: United States